Literature DB >> 27383917

Lupus nephritis: NRF2, a novel target in steroid-refractory LN?

Caroline Barranco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27383917     DOI： 10.1038/nrrheum.2016.116

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Nuclear factor erythroid 2-related factor 2 is a critical target for the treatment of glucocorticoid-resistant lupus nephritis.

Authors:  Shin Ebihara; Hideaki Tajima; Masao Ono
Journal:  Arthritis Res Ther       Date:  2016-06-14       Impact factor: 5.156
  1 in total
  2 in total

1.  Cytochrome P450 2E1-deficient MRL+/+ mice are less susceptible to trichloroethene-mediated autoimmunity: Involvement of oxidative stress-responsive signaling pathways.

Authors:  Gangduo Wang; Maki Wakamiya; Jianling Wang; G A Shakeel Ansari; M Firoze Khan
Journal:  Free Radic Biol Med       Date:  2019-08-22       Impact factor: 7.376

2.  Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2/HO-1 in myeloid-derived suppressor cells.

Authors:  Dan Li; Guoping Shi; Jiali Wang; Dongya Zhang; Yuchen Pan; Huan Dou; Yayi Hou
Journal:  Arthritis Res Ther       Date:  2019-04-25       Impact factor: 5.156
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.